Logotype for Aker BioMarine

Aker BioMarine (AKBM) investor relations material

Aker BioMarine Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Aker BioMarine
Q3 2025 earnings summary31 Oct, 2025

Executive summary

  • Q3 2025 revenue reached USD 56.8 million, up 15% year-over-year, with adjusted EBITDA of USD 12.2 million, a 50% increase year-over-year, driven by strong Human Health Ingredients performance and new Superba Krill Oil contracts.

  • Human Health Ingredients segment delivered 23% revenue growth to USD 30.2 million and 35% higher adjusted EBITDA to USD 13.5 million, with robust performance in China and Asia-Pacific and improved margins from higher volumes and better pricing.

  • Consumer Health Products revenue declined 6% year-over-year to USD 27.4 million, but EBITDA margin remained stable due to improved gross margin and inventory normalization.

  • Emerging Business segment reported stable revenue at USD 2.0–2.1 million and negative EBITDA narrowing to USD -0.4 million, with progress toward break-even and reduced opex.

  • Secured significant new business for Superba Krill Oil and launched Kori XL in Consumer Health.

Financial highlights

  • Gross profit for Q3 2025 was USD 24.9 million, up from USD 17.7 million in Q3 2024, with gross margin rising to 44% from 36% year-over-year.

  • Net profit from continued operations was USD 2.5 million, compared to USD 1.4 million in Q3 2024.

  • Net interest-bearing debt at USD 165 million, leverage at 4x net debt/Adjusted EBITDA, and equity ratio at 38%.

  • Positive cash flow from operations in Q3 of USD 0.4 million; cash balance at USD 7.4 million and total available liquidity at USD 18.4 million.

  • Net working capital at USD 107–118 million, reflecting inventory and payables changes.

Outlook and guidance

  • Human Health Ingredients expected to maintain strong growth and profitability, with Q3 revenues anticipated to be similar to Q2, followed by further growth.

  • Consumer Health Products projected to return to modest growth as inventory issues normalize and market demand stabilizes.

  • Emerging Business nearing cash break-even, with ongoing transaction activity and reduced materiality.

  • Corporate costs expected between USD 12 million and USD 14 million going forward.

  • Company executing cost and productivity initiatives to improve efficiency amid macroeconomic uncertainty and new tariffs.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Aker BioMarine earnings date

Logotype for Aker BioMarine
Q4 202512 Feb, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Aker BioMarine earnings date

Logotype for Aker BioMarine
Q4 202512 Feb, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications. Aker BioMarine AS operates through Fish Oils and Pelagic Protein segments. Its products include astaxanthin; fish oil; EPA; acetyl-L-carnitine (ALCAR); omega-3 phospholipids; and omega-3 fatty acids. It also offers products that contain its products that contain astaxanthin in skin care preparations. Aker BioMarine AS markets its products under the AkerBioSolutions brand to food companies and manufacturers of dietary supplements, as well as to producers of livestock feed for hens and pigs.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage